Implants

Staar Surgical has seen its stock jump more than 30% in the past month, prompting investors to wonder what's behind the sudden move. An analyst offers a few scenarios that might be driving interest in the stock.

These are the companies in the private sector that medtech analysts have called attention to in 2020.

Results from the SCOPE II trial were presented at TCT Connect and showed the Acurate Neo failed to demonstrate non-inferiority when compared to Medtronic’s CoreValve Evolut.

In an exclusive MD+DI interview, Medtronic leaders spotlight the company's pelvic health business in advance of analyst day.

BlueWind Medical has launched a pivotal trial of its Renova iStim implantable tibial neuromodulation system for the treatment of overactive bladder. The device could offer a less invasive alternative to sacral nerve stimulation, a market that...

The company reached agreements with plaintiff law firms to resolve roughly 90% of the nearly 39,000 total filed and unfiled U.S. Essure claims involving women who allege device-related injuries.